Bajaj Life Insurance to Apply for Pension Fund Manager and GIFT City Licenses
Bilkul Bazaar Pune, Ahmedabad | 06 Feb 2026 Bajaj Life Insurance, one of the leading private life insurers in India,
Read More
Governance & Opposition
Announcements and Opposition regarding Business related actions, policies etc
Trade deal unlocks access to $572.3 billion EU pharmaceuticals and medical devices market
Bilkul Bazaar New Delhi | 28 Jan 2026 The free trade agreement (FTA) between India and the European Union (EU)
Read More
Dabur Modernises Ayurveda with New Packaging, Knowledge Forums and Community Health Outreach
Dabur Modernises Ayurveda for the New Generation Bilkul Bazaar Ahmedabad | 13 January 2026 Ahmedabad, 12 January 2026: Dabur India
Read More
States must play bigger role in India’s tech self-reliance, Viksit Bharat goals: NITI Aayog Vice Chairman
Bilkul Bazaar New Delhi | 11 Jan 2026 State institutions must take on a much bigger role in research, development
Read More
FAIFA urges government to roll back steep tax hike on tobacco products
Bilkul Bazaar New Delhi | 2 Jan 2026 The Federation of All India Farmer Associations (FAIFA) on Friday urged the
Read More
Sun Pharma slips as USFDA classifies Gujarat plant under OAI status
Bilkul Bazaar Mumbai | 18 Dec 2025 Shares of Sun Pharmaceutical Industries fell sharply on Thursday after the US drug
Read More
India–Russia ink postal agreement to boost cross-border e-commerce
Bilkul Bazaar New Delhi | 06 Dec 2025 India’s Department of Posts and JSC Russia Post on Friday signed a
Read More
Veeda Lifesciences and Cytiva drive biopharma innovation with new host cell protein services center
Bilkul Bazaar Collaboration to facilitate advanced biologics testing by providing HCP coverage, characterization and quantification assays, and related services to
Read More
Healthcare industry calls for a major boost in Union Budget 2026-27
Bilkul Bazaar New Delhi | 27 Nov 2025 The healthcare industry on Thursday urged the government to invest in robust
Read More
Alembic Pharma Gets USFDA Nod for Diltiazem Tablets
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120
Read More